Send to a Friend Share

Illumina (ILMN) Competitors Jump Higher On Roche Bid (GNOM) (AFFX) (PACB) (more...)

January 25, 2012 9:53 AM EST
ILMN Hot Sheet
Overall Analyst Rating:
    NEUTRAL (= Flat)

Revenue Growth %: -3.4%
A number of Illumina, Inc. (NASDAQ: ILMN) peers are trading higher after Roche launched a $44.50 hostile takeover bid for Illumina, Inc. (NASDAQ: ILMN). Shares of Illumina are actually trading above the offer on hopes of a higher bid.

Around the sector:
Complete Genomics, Inc. (NASDAQ: GNOM) up 21%
Pacific Biosciences of Californ (NASDAQ: PACB) up 14%
Affymetrix, Inc. (NASDAQ: AFFX) up 7%
Life Technologies Corporation (Nasdaq: LIFE) up 4%
Sequenom, Inc. (Nasdaq: SQNM) up 2%
Qiagen N.V. (Nasdaq: QGEN) up 1%
Luminex Corporation (Nasdaq: LMNX) up 1%


Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In


Related Categories

Rumors, Trader Talk

Add Your Comment





Follow StreetInsider.com On Twitter